Newsroom
Category
July 23, 2020
In this video, Ruben A. Mesa, MD, director of the Mays Cancer Center at UT Health San Antonio MD Anderson Cancer Center, discusses the potential clinical benefit of rechallenging with JAK inhibitor therapy in patients with myeloproliferative neoplasms (MPNs). Watch the interview.
July 20, 2020
Ruben Mesa, MD, director of the Mays Cancer Center, discusses recent data with momelotinib in myelofibrosis. Read and watch the story.
July 16, 2020
New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature.
July 13, 2020
Dr. Ruben Mesa, Mays Cancer Center Director, contributes to The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology. Read the story.
July 6, 2020
Darpan Patel, PhD, a faculty member in the School of Nursing, and Pratap Kumar, PhD, in the Department of Molecular Medicine, explain why cork tree bark, an herbal remedy that’s been around for centuries, is being studied as a way to shrink prostate tumors.
June 26, 2020
Our cells are constantly dividing, and as they do, the DNA molecule – our genetic code – sometimes gets broken. DNA has twin strands, and a break in both is considered especially dangerous. This kind of double-strand break can lead to genome rearrangements that are hallmarks of cancer cells, said James Daley, PhD, of the […]
